DART KENNETH BRYAN 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jul 21, 2017
Insider Transaction Report
Form 4
Eastern Capital LTD
10% Owner
Transactions
- Purchase
Common Stock
2017-07-19$2.00/sh+850,000$1,700,000→ 2,167,261 total - Purchase
Warrant
2017-07-19+1→ 1 totalExercise: $2.00→ Common Stock (850,000 underlying)
Footnotes (1)
- [F1]On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.